Barbara Hero

15.4k citations
172 papers · 8.9k · 1 hit paper · h-index 50

Impact in

  • Neurology top 0.05%
    • Neuroblastoma Research and Treatments
    • Neurofibromatosis and Schwannoma Cases
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Neuroblastoma Research and Treatments 135
    • Autoimmune Neurological Disorders and Treatments 9
    • Cancer therapeutics and mechanisms 18

Barbara Hero

168 papers receiving 8.6k citations

Barbara Hero's Hit Papers

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report 2008 · 1.3k citations
1.3k0+6+12Years since publication4008001.2k

Peers

Barbara Hero
Comparison fields: 5 of 119
  • Neurology 6.4k
  • Cancer Research 1.8k
  • Oncology 1.2k
  • Genetics 465
  • Molecular Biology 2.9k
Replace Victoria Castel with:
Victoria Castel Spain
Robert B. Gerbing United States
Bruno De Bernardi Italy
Dominique Valteau‐Couanet France
Julie R. Park United States
Ruth Ladenstein Austria
Véronique Mosseri France
Birgit Geoerger France
F. Ann Hayes United States
Uri Tabori Canada
Barbara Hero relative to Victoria Castel Spain Victoria Castel's profile →
Citations per field
00.5×1.5×2.2×
Victoria Castel · 1×
Citations per year

Countries citing papers authored by Barbara Hero

Since Specialization
Citations

This map shows the geographic impact of Barbara Hero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Hero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Hero more than expected).

Fields of papers citing papers by Barbara Hero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Hero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Hero. The network helps show where Barbara Hero may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Hero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Hero Line = papers co-authored together Barbara Hero links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Hit paper breakdown →
20081339
2 2008333
3 2011332
4 2005288
5 2002277
6 2003242
7 2001241
8 2006213
9 2008212
10 2008190
11 2013165
12 2004152
13 2014141
14 2004111
15 2005111
16 2014109
17 2011106
18 201097
19
Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
200397
20
Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.
201696

About Barbara Hero

Barbara Hero is a scholar working on Neurology, Molecular Biology, Cancer Research, Oncology and Surgery, having authored 172 papers that have together received 8.9k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (135 papers), Cancer, Hypoxia, and Metabolism (26 papers), Cancer therapeutics and mechanisms (18 papers), Lung Cancer Research Studies (10 papers), Autoimmune Neurological Disorders and Treatments (9 papers), Neuroendocrine Tumor Research Advances (9 papers), Adrenal and Paraganglionic Tumors (6 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Neurology (6.4k citations), Cancer Research (1.8k citations), Oncology (1.2k citations), Genetics (465 citations) and Molecular Biology (2.9k citations). Barbara Hero has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Frank Berthold, Thorsten Simon, Matthias Fischer, Frank Westermann, Andreas Faldum, Katherine K. Matthay, Wendy B. London, Andrew D.J. Pearson, Susan L. Cohn and Tom Monclair. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, European Journal of Cancer, Clinical Cancer Research and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact